Pharmacology: Moclobemide Moclobemide is classified as an antidepressant, a MAO (monoamine oxidase) inhibitor. Antidepressants are designed to inhibit the reuptake or reabsorbtion of specific neurotransmitters, increasing the levels of these neurotransmitters around the nerves of the brain (Gbemudu, 2011:1). Neurotransmitters such as serotonin, dopamine and norepinephrine (noradrenaline) are often called 'feel good' chemicals that elevate the patient's mood. Drug class A deficit of mood-enhancing chemicals is associated with depression, although there is no

This creates stress, but also makes his sedentary for most of the day. As a truck driver, he spends most of his work day in a seated position, with limited exercise or strenuous movements. Additionally, Mr. J. has no health insurance. As such, he has limited access to care, which often places him in danger of not getting his needed medicines, but also of not taking them in a

Patient Scenario Components of the Physical Examination -- The basic components of the physical exam can be delineated into four major pars: 1) Inspection, 2) Palpation, 3) Percussion, 4) Auscultation: Inspection -- assess breathing abnormalities, cough, patient color, stained fingers, neck, thorax; focus on abnormal reactions, color, movement, or sound. Palpation -- indicates tender areas, observed abnormalities, respiratory expansion, vibration Percussion -- audible sounds when chest wall is percussed; dull or flat or resonant;

One drug that is very commonly used for depression is Prozac (by Eli Lilly), which contains an "inhibitor" called fluoxetine; another inhibitor is called "phenelzine" and its commercial antidepressant drug is Nardil (by Parke-Davis drug company), which falls under the category of "Monoamine oxidase inhibitor" (MAOI) (Friedlander, p. 632). The problem with some of these medications, like MAOI for example, is they may cause "dizziness… hypotension, insomnia, central nervous system

In conclusion, much academic attention has been spent on the role of serotonin deficiency and its role in depression and other mood disorders. There has been increasing attention on developing SSRIs that are target-specific in an attempt to reduce unwanted side effects. However, as we have seen too much serotonin many have lasting effects on the brain and contribute to elderly dementia, or permanent damage to the hippocampus. It appears that

Psychopharmacology It was only in the 1950s when psychiatric drugs to treat severe depression were first developed. Prior to that, most people had to suffer with their emotional pain and its attached sigma. Many individuals had to be admitted to mental hospitals. Now, psychiatrists can prescribe any of hundreds of medications for this illness and, in the majority of cases, have successful results. Monoamine Oxidase Inhibitors or MAOs were the first pharmaceuticals